Cargando…
Perindopril Induces TSP-1 Expression in Hypertensive Patients with Endothelial Dysfunction in Chronic Treatment
Thrombospondin-1 (TSP-1) is a potent endogenous inhibitor of both physiological and pathological angiogenesis, widely studied as a target in drug development for treating cancer. Several studies performed in the cardiovascular field on TSP-1 are contradictory, the role of TSP-1 in the physiopatholog...
Autores principales: | Buda, Valentina, Andor, Minodora, Petrescu, Lucian, Cristescu, Carmen, Baibata, Dana Emilia, Voicu, Mirela, Munteanu, Melania, Citu, Ioana, Muntean, Calin, Cretu, Octavian, Tomescu, Mirela Cleopatra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343883/ https://www.ncbi.nlm.nih.gov/pubmed/28178210 http://dx.doi.org/10.3390/ijms18020348 |
Ejemplares similares
-
Thrombospondin-1 Serum Levels In Hypertensive Patients With Endothelial Dysfunction After One Year Of Treatment With Perindopril
por: Buda, Valentina, et al.
Publicado: (2019) -
Comparative Solid-State Stability of Perindopril Active Substance vs. Pharmaceutical Formulation
por: Buda, Valentina, et al.
Publicado: (2017) -
Decreased sEng plasma levels in hypertensive patients with endothelial dysfunction under chronic treatment with Perindopril
por: Buda, Valentina, et al.
Publicado: (2019) -
The Predictive Value of Endothelial Inflammatory Markers in the Onset of Schizophrenia
por: Radu, Gabriela, et al.
Publicado: (2020) -
Nebivolol effect on doxorubicin-induced cardiotoxicity in breast cancer
por: Cochera, Flavia, et al.
Publicado: (2018)